SuperGen, Stehlin Foundation for Cancer Research deal

SUPG acquired exclusive worldwide rights from the foundation to RFS 2000, an oral

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE